Opportunity Information: Apply for PA 15 112
Apply for PA 15 112
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Gene Environment Interplay in Substance Use Disorders (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273 Alcohol Research Programs 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Feb 5, 2015 and posted on Feb 5, 2015.
- Applicants must submit their applications by Sep 7, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: Small businesses Public housing authorities/Indian housing authorities Special district governments State governments County governments Public and State controlled institutions of higher education Private institutions of higher education Independent school districts For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal governments (Federally recognized).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Gene Environment Interplay in Substance Use Disorders (R21) funding opportunity (PA 15-112) is a National Institutes of Health (NIH) discretionary grant program designed to spark new, exploratory research on how genetic factors and environmental influences combine to shape substance and alcohol use disorders (SUDs). The core idea is that decades of genetic epidemiology and molecular genetics research have shown SUDs to be highly heritable and strongly developmental in nature, meaning risk and outcomes unfold over time and are influenced by both inherited liabilities and life context. This FOA encourages projects that move beyond studying genetics or environment in isolation and instead directly examine how the two interact to affect the onset of use, escalation to disorder, persistence or remission, relapse, and downstream consequences.
A major emphasis is on using genetically informative approaches to clarify the complex pathways linking genes, environments, and developmental trajectories. In practice, that can include study designs and methods capable of separating or jointly modeling inherited risk and contextual exposures, and capturing how those relationships change across adolescence, young adulthood, and later life. The announcement highlights the need for research that also addresses comorbidity, since SUDs frequently co-occur with other psychiatric or behavioral conditions, and gene-environment interplay may help explain why certain combinations of disorders cluster together or why some individuals experience more severe courses than others.
The FOA also signals interest in improving and refining phenotypes, meaning the way SUDs and related traits are defined and measured. Rather than relying only on broad diagnostic categories, applicants are encouraged to sharpen measurement of substance involvement, progression, impairment, withdrawal, craving, treatment response, and adverse outcomes, as well as environmental exposures that might shape risk (for example, stress, trauma, peer and family context, neighborhood factors, policy environment, or access to substances). The goal is to produce more precise, informative characterizations of both the disorder and the environments in which it develops, which can strengthen interpretation of genetic findings and improve the ability to detect meaningful interaction effects.
Another explicit goal is to tackle methodological challenges in the field. Gene-environment research is notoriously complex because exposures can be correlated with genetic background, effects can vary across development, and measurement and sampling issues can distort results. By calling out these challenges, NIH is encouraging innovative strategies that improve causal inference, study design, measurement validity, and analytic approaches so that findings more accurately reflect the true contributions of genetics and environment. Ultimately, the FOA frames these projects as foundational: better understanding of risk mechanisms can lead to stronger opportunities for translation into prevention and treatment, and can also inform future gene-finding and molecular studies by identifying clearer targets and more informative subgroups.
From an administrative standpoint, this is an NIH grant using the R21 mechanism, which is typically intended for exploratory or developmental work, such as piloting new approaches, generating preliminary data, or testing emerging hypotheses that could later be scaled into larger studies. The award ceiling listed is $200,000, and there is no cost sharing or matching requirement. The opportunity was posted on February 5, 2015, with an original and current closing date of September 7, 2017, and an archive date of October 8, 2017, meaning it is no longer open but remains a useful reference point for the type of research NIH sought to stimulate at that time.
Eligible applicants are broad and include many types of U.S. and non-U.S. institutions and organizations. Examples include state, county, and local governments; public and private institutions of higher education; independent school districts; special district governments; small businesses; other for-profit organizations (excluding small businesses in that category); and nonprofits with or without 501(c)(3) status (with distinctions noted for institutions of higher education). The eligibility list also explicitly includes groups such as federally recognized and other tribal governments, tribal organizations, tribally controlled colleges and universities, historically Black colleges and universities, Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, and Asian American, Native American, and Pacific Islander-serving institutions. Faith-based or community-based organizations, U.S. territories or possessions, and foreign organizations or other non-domestic entities are also listed as eligible. The relevant CFDA program areas are 93.273 (Alcohol Research Programs) and 93.279 (Drug Abuse and Addiction Research Programs).
For full details, NIH pointed applicants to the official guide notice page at http://grants.nih.gov/grants/guide/pa-files/PA-15-112.html and provided NIH Office of Extramural Research (OER) webmaster contacts for access or linking issues.
Frequently Asked Questions (FAQs)
What is the Gene Environment Interplay in Substance Use Disorders (R21) opportunity (PA-15-112)?
It is a National Institutes of Health (NIH) discretionary funding opportunity that used the R21 grant mechanism to encourage new, exploratory research on how genetic factors and environmental influences work together to shape substance and alcohol use disorders (SUDs).
What is the main scientific focus of this funding opportunity?
The focus is on gene-environment interplay in SUDs: projects that move beyond studying genetics or environment in isolation and instead directly examine how they interact to affect the onset of substance use, escalation to disorder, persistence or remission, relapse, and downstream consequences.
What types of disorders does this opportunity cover?
The opportunity is focused on substance and alcohol use disorders (SUDs), including developmental patterns and outcomes over time.
Why does NIH emphasize development and timing (adolescence, young adulthood, later life) in this FOA?
The FOA highlights that SUDs are strongly developmental in nature, meaning risk and outcomes unfold over time. It encourages research that captures how genetic and environmental relationships may change across adolescence, young adulthood, and later life.
What does NIH mean by "gene-environment interplay" in the context of SUD research?
In this FOA, gene-environment interplay refers to research that examines how inherited liabilities and life context combine to influence substance-related outcomes, including how genetic background and contextual exposures jointly shape trajectories and severity.
What kinds of research approaches are encouraged?
The FOA encourages genetically informative approaches designed to clarify pathways linking genes, environments, and developmental trajectories. This includes designs and methods capable of separating or jointly modeling inherited risk and environmental exposures, and tracking how those relationships change over time.
Does the FOA encourage studying comorbidity with other psychiatric or behavioral conditions?
Yes. The announcement explicitly notes that SUDs frequently co-occur with other psychiatric or behavioral conditions and encourages research examining whether gene-environment interplay helps explain clustering of disorders or more severe courses in some individuals.
What does the FOA say about improving "phenotypes"?
It encourages refining how SUDs and related traits are defined and measured. Rather than relying only on broad diagnostic categories, it supports more precise measurement of substance involvement and progression, impairment, withdrawal, craving, treatment response, adverse outcomes, and relevant environmental exposures.
What kinds of environmental exposures are mentioned as relevant?
Examples provided include stress, trauma, peer and family context, neighborhood factors, policy environment, and access to substances.
Why is measurement and phenotype refinement important for this FOA?
The FOA frames more precise measurement as a way to strengthen interpretation of genetic findings and improve the ability to detect meaningful interaction effects between genes and environment.
What methodological challenges does NIH highlight for gene-environment research?
The FOA notes that gene-environment research is complex because environmental exposures can be correlated with genetic background, effects can vary across development, and measurement and sampling issues can distort results. It encourages innovative strategies to improve causal inference, study design, measurement validity, and analytic approaches.
What is the intended purpose of using the NIH R21 mechanism for this FOA?
The R21 mechanism is typically intended for exploratory or developmental work. In this FOA, it is positioned for piloting new approaches, generating preliminary data, or testing emerging hypotheses that could later be scaled into larger studies.
What is the funding cap for awards under this opportunity?
The award ceiling listed is $200,000.
Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement.
When was this opportunity posted, and what were the closing dates?
It was posted on February 5, 2015. The original and current closing date listed is September 7, 2017, and the archive date is October 8, 2017.
Is this funding opportunity still open?
No. Based on the closing and archive dates provided, it is no longer open. It remains available as a reference point for the type of research NIH aimed to stimulate at that time.
Who is eligible to apply?
Eligibility is broad and includes many U.S. and non-U.S. institutions and organizations. Examples listed include state, county, and local governments; public and private institutions of higher education; independent school districts; special district governments; small businesses; other for-profit organizations (excluding small businesses in that category); and nonprofits with or without 501(c)(3) status (with distinctions noted for institutions of higher education).
Are tribal governments and tribal organizations eligible?
Yes. The eligibility list explicitly includes federally recognized and other tribal governments, tribal organizations, and tribally controlled colleges and universities.
Are minority-serving institutions eligible?
Yes. The eligibility list explicitly includes historically Black colleges and universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, and Asian American, Native American, and Pacific Islander-serving institutions.
Are faith-based or community-based organizations eligible?
Yes. Faith-based or community-based organizations are explicitly listed as eligible.
Are U.S. territories or possessions eligible?
Yes. U.S. territories or possessions are listed as eligible.
Are foreign organizations eligible to apply?
Yes. Foreign organizations or other non-domestic entities are included in the eligibility list.
What are the CFDA program areas associated with this opportunity?
The CFDA program areas listed are 93.273 (Alcohol Research Programs) and 93.279 (Drug Abuse and Addiction Research Programs).
Where can applicants find the official NIH posting for PA-15-112?
NIH directed applicants to the official guide notice page at http://grants.nih.gov/grants/guide/pa-files/PA-15-112.html.
Who was listed as a contact for access or linking issues?
The NIH Office of Extramural Research (OER) webmaster contacts were provided for access or linking issues.
What kinds of outcomes and stages of SUD does the FOA want projects to address?
The FOA highlights outcomes and stages such as onset of use, escalation to disorder, persistence or remission, relapse, and downstream consequences.
How does the FOA describe the longer-term value of these exploratory projects?
It frames them as foundational: improved understanding of risk mechanisms can create stronger opportunities for translation into prevention and treatment, and can inform future gene-finding and molecular studies by identifying clearer targets and more informative subgroups.
Browse more opportunities from the same category: Education Health
Next opportunity: ROSES 2014 Extreme Precision Doppler Spectrometer Instrument
Previous opportunity: National Coastal Wetland Conservation Grant Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 15 112
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 15 112) also looked into and applied for these:
| Funding Opportunity |
|---|
| Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01) Apply for RFA DA 16 001 Funding Number: RFA DA 16 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12) Apply for PAR 15 119 Funding Number: PAR 15 119 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Identification of Genetic and Genomic Variants by Next Gen in Sequencing Non human Animal Models (U01) Apply for PAR 15 120 Funding Number: PAR 15 120 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| BRAIN Initiative Optimization of Novel Tools and Technologies for Neuroscience Research (R44) Apply for PAR 15 121 Funding Number: PAR 15 121 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Functional Wellness in HIV Maximizing the Treatment Cascade (R01) Apply for PA 15 133 Funding Number: PA 15 133 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Functional Wellness in HIV Maximizing the Treatment Cascade (R21) Apply for PA 15 134 Funding Number: PA 15 134 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Administrative Supplements for Research on HIV/AIDS and Aging (Admin Supp) Apply for PA 15 137 Funding Number: PA 15 137 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics and Prognostics Toward Commercialization (R44) Apply for RFA CA 15 010 Funding Number: RFA CA 15 010 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| International Research Collaboration on Drug Abuse and Addiction Research (R03) Apply for PA 15 141 Funding Number: PA 15 141 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| International Research Collaboration on Drug Abuse and Addiction Research (R01) Apply for PA 15 142 Funding Number: PA 15 142 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| International Research Collaboration on Drug Abuse and Addiction Research (R21) Apply for PA 15 143 Funding Number: PA 15 143 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Limited Competition Revisions to Add Phase 2 Clinical Trials Program to Experimental Therapeutics Clinical Trials Network (ETCTN)(UM1) Apply for RFA CA 15 501 Funding Number: RFA CA 15 501 Agency: National Institutes of Health Category: Education Health Funding Amount: $560,000 |
| Cancer Research Education Grants Program Research Experiences (R25) Apply for PAR 15 152 Funding Number: PAR 15 152 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Cancer Research Education Grants Program Courses for Skills Development (R25) Apply for PAR 15 151 Funding Number: PAR 15 151 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Cancer Research Education Grants Program Curriculum or Methods Development (R25) Apply for PAR 15 150 Funding Number: PAR 15 150 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Administrative Supplements to Promote Cancer Prevention and Control Research in Low and Middle Income Countries (Admin Supp) Apply for PAR 15 155 Funding Number: PAR 15 155 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions (R21) Apply for RFA CA 15 009 Funding Number: RFA CA 15 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions (R01) Apply for RFA CA 15 008 Funding Number: RFA CA 15 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Regional Medical Libraries for the National Network of Libraries of Medicine (UG4) Apply for RFA LM 15 003 Funding Number: RFA LM 15 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34) Apply for PA 15 177 Funding Number: PA 15 177 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 15 112", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.